Transdermal Lidocaine Administration Prior to Insertion Levonorgestrel-releasing Intrauterine System

IUCD Complication Clinical Trial

Official title:
Clinical Outcomes of Transdermal Lidocaine Administration Prior to Levonorgestrel Releasing Intrauterine System Insertion in Women Delivered Only by Elective Cesarean Section: a Randomized Double Blinded Clinical Trial

Status Recruiting

Clinical Trial Summary

aims to investigate the effectiveness of Transdermal lidocaine patch for Pain Control During Levonorgestrel Releasing Intrauterine System Insertion in Women Delivered Only by Elective Cesarean Section

Clinical Trial Description

Long-acting reversible contraception methods are highly effective methods for reduction of the unplanned pregnancy rate worldwide. The intrauterine device is a single procedure that provides reliable, effective and long term contraception for many women. However, the insertion procedure can be associated with a troublesome degree of pain that prevent some women from choosing its use. Different interventions have been described to decrease pain perception during intrauterine device insertion with no agreement on an effective one. ;

Study Design

Related Conditions & MeSH terms

IUCD Complication

Clinical Trial Details

NCT number	NCT04517890
Study type	Interventional
Source	Aswan University Hospital
Contact	hany f Sallam, md
Phone	+20102435461
Email	hany.farouk@aswu.edu.eg
Status	Recruiting
Phase	N/A
Start date	September 1, 2020
Completion date	September 1, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04505657` - Lidocaine Spray Plus Oral Celecoxib for Pain Control During Hysterosalpingography	N/A
Not yet recruiting	`NCT04505943` - Vaginal Misoprostol and Dinoprostone and Isonicotinic Acid Hydrazide Prior to Copper Intrauterine Device Insertion	N/A
Not yet recruiting	`NCT04505917` - Vaginal Misoprostol and Dinoprostone Prior to Copper Intrauterine Device Insertion in Women	N/A
Completed	`NCT04499989` - Vaginal Isonicotinic Acid Hydrazide (INH) Administration Prior to T380A Intrauterine Device Insertion	Phase 4
Not yet recruiting	`NCT04500002` - Isonicotinic Acid Hydrazide (INH) Pretreatment With Misoprostol Versus Misoprostol Alone in Missed Abortion	N/A
Completed	`NCT04500015` - Vaginal Isonicotinic Acid Hydrazide Administration Prior to Intrauterine Device Insertion	Phase 4
Completed	`NCT04500028` - Vaginal Isonicotinic Acid Hydrazide Administration Prior to Insertion Levonorgestrel-releasing Intrauterine System	Phase 4